Literature DB >> 18568429

Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan.

Atsuko Fujita1, Naoto Tomita, Hiroyuki Fujita, Kenji Motohashi, Rie Hyo, Etsuko Yamazaki, Michiko Hattori, Shin Fujisawa, Heiwa Kanamori, Koji Ogawa, Shigeki Motomura, Fumio Kodama, Yoshiaki Ishigatsubo.   

Abstract

We sought to determine the frequency of primary extranodal lymphoma (ENL) and its characteristics in Kanagawa, a human T-cell leukemia virus type 1 (HTLV-1) nonendemic area in Japan. Subjects were 847 newly diagnosed patients with malignant lymphoma at the Yokohama City University Hospital and 8 affiliated hospitals mainly located in Kanagawa prefecture from 1999 to 2005. We compared the clinicopathological characteristics of primary ENL with primary nodal lymphoma (NL). Histological specimens were evaluated according to the World Health Organization classifications. A total of 395 (46.6%) and 452 (53.4%) patients had primary ENL and primary NL, respectively. The frequency of primary ENL increased with age. Primary extranodal sites included the gastrointestinal tract (30.4%), Waldeyer's ring (17.8%), orbits (7.0%), soft tissue and subcutaneous tissue (5.2%), bone (4.6%), skin (4.3%), thyroid gland (4.3%), testis and prostate (3.3%), bone marrow (3.3%), nasal and paranasal cavities (2.6%), salivary glands (2.3%), lung and pleura (2.0%), breast (1.8%), central nervous system (1.0%), uterus and ovary (0.5%), and others (9.8%). Among the 395 cases of primary ENL, diffuse large B-cell lymphoma (61.2%) was most frequently diagnosed, followed by extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (13.3%) and follicular lymphoma (5.6%). The frequency of primary ENL is approximately 50% of the total lymphoma cases in Kanagawa, an HTLV-1 nonendemic area in Japan. This frequency appears to be higher than that in Western countries.

Entities:  

Mesh:

Year:  2008        PMID: 18568429     DOI: 10.1007/s12032-008-9080-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  17 in total

Review 1.  [Clinical features of extranodal malignant lymphoma--staging classification and treatment strategies].

Authors:  T Takagi
Journal:  Rinsho Ketsueki       Date:  1999-03

2.  Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases.

Authors:  Michael B Møller; Niels T Pedersen; Bjarne E Christensen
Journal:  Br J Haematol       Date:  2004-01       Impact factor: 6.998

3.  The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiologic factors. Proceedings of a workshop. Bethesda, Maryland, October 22-23, 1991.

Authors: 
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

4.  Non-Hodgkin's lymphoma time trends: United States and international data.

Authors:  S S Devesa; T Fears
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

5.  Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.

Authors:  Armando López-Guillermo; Luis Colomo; Mónica Jiménez; Francesc Bosch; Neus Villamor; Leonor Arenillas; Ana Muntañola; Silvia Montoto; Eva Giné; Dolors Colomer; Silvia Beà; Elías Campo; Emili Montserrat
Journal:  J Clin Oncol       Date:  2005-02-22       Impact factor: 44.544

Review 6.  Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic.

Authors:  D D Weisenburger
Journal:  Ann Oncol       Date:  1994       Impact factor: 32.976

7.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

8.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Intravascular lymphomatosis--an indolent or aggressive entity?

Authors:  V Bogomolski-Yahalom; I S Lossos; E Okun; Y Sherman; A Lossos; A Polliack
Journal:  Leuk Lymphoma       Date:  1998-05

10.  Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group.

Authors:  F d'Amore; B E Christensen; H Brincker; N T Pedersen; K Thorling; J Hastrup; M Pedersen; M K Jensen; P Johansen; E Andersen
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

View more
  4 in total

Review 1.  Thyroid lymphoma: recent advances in diagnosis and optimal management strategies.

Authors:  Siun Walsh; Aoife J Lowery; Denis Evoy; Enda W McDermott; Ruth S Prichard
Journal:  Oncologist       Date:  2013-07-23

2.  12 cases of primary thyroid lymphoma in China.

Authors:  L Yang; A Wang; Y Zhang; Y Mu
Journal:  J Endocrinol Invest       Date:  2015-03-04       Impact factor: 4.256

3.  Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution.

Authors:  Qun-Pei Yang; Wen-Yan Zhang; Jian-Bo Yu; Sha Zhao; Huan Xu; Wei-Ya Wang; Cheng-Feng Bi; Zhuo Zuo; Xiao-Qing Wang; Juan Huang; Lin Dai; Wei-Ping Liu
Journal:  Diagn Pathol       Date:  2011-08-22       Impact factor: 2.644

4.  Clinicopathological study and outcomes of primary extranodal lymphoma.

Authors:  Nichapa Nanthakwang; Ekarat Rattarittamrong; Thanawat Rattanathammethee; Chatree Chai-Adisaksopha; Adisak Tantiworawit; Lalita Norrasethada; Charin Ya-In
Journal:  Hematol Rep       Date:  2019-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.